Cawkwell Gail is Chief Medical Officer of Aclaris Therapeutics Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Aclaris Therapeutics, Inc.
5 Jul 23
4
Aclaris Therapeutics, Inc.
3 Feb 23
4
Aclaris Therapeutics, Inc.
5 Jul 22
3
Aclaris Therapeutics, Inc.
5 Jul 22
4
INTERCEPT PHARMACEUTICALS, INC.
15 Feb 22
4
INTERCEPT PHARMACEUTICALS, INC.
31 Jan 22
4
INTERCEPT PHARMACEUTICALS, INC.
4 Jan 22
4
INTERCEPT PHARMACEUTICALS, INC.
16 Nov 21
4
INTERCEPT PHARMACEUTICALS, INC.
13 Aug 21
4
INTERCEPT PHARMACEUTICALS, INC.
13 May 21
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
1 Feb 23 | ACRS Aclaris Therapeutics | RSU Common Stock | Grant | Acquire A | No | No | 0 | 30,000 | 0.00 | 30,000 |
1 Feb 23 | ACRS Aclaris Therapeutics | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 16.97 | 105,000 | 1.78 mm | 105,000 |